MARKET

SVA

SVA

Sinovac Biotech Ltd
NASDAQ
6.47
0.00
0.00%
Suspension 04:00 09/25 EDT
OPEN
6.47
PREV CLOSE
6.47
HIGH
6.47
LOW
6.47
VOLUME
0
TURNOVER
0
52 WEEK HIGH
6.58
52 WEEK LOW
6.25
MARKET CAP
388.59M
P/E (TTM)
-4.9314
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SVA last week (0126-0130)?
Weekly Report · 5d ago
Sinovac Wins Conditional Nasdaq Reprieve as Panel Grants Continued Listing
TipRanks · 01/30 20:48
Sinovac Receives New Nasdaq Compliance Notice Ahead of January Delisting Hearing
TipRanks · 01/30 20:48
Sinovac Biotech Board Secures Interim Control Under Antigua Court Order Amid Governance Dispute
TipRanks · 01/30 20:48
Sinovac Faces Nasdaq Delisting Over Delayed 2024 Annual Report, Plans Appeal
TipRanks · 01/30 20:47
Sinovac Appoints UHY as Independent Auditor to Restore SEC and Nasdaq Compliance
TipRanks · 01/30 20:47
Sinovac Biotech Reshapes Board Committees and Forms Litigation Panel After August 19 Meeting
TipRanks · 01/30 20:47
Weekly Report: what happened at SVA last week (0119-0123)?
Weekly Report · 01/26 10:05
More
About SVA
Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.

Webull offers Sinovac Biotech Ltd stock information, including NASDAQ: SVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SVA stock methods without spending real money on the virtual paper trading platform.